Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Artesunate

This page shows the latest Artesunate news and features for those working in and with pharma, biotech and healthcare.

WHO to test three more potential COVID-19 treatments

WHO to test three more potential COVID-19 treatments

The expanded Solidarity PLUS trial will test artesunate, imatinib and infliximab on hospitalised COVID-19 patients in a trial that will involve thousands of researchers in 52 countries. ... The drugs – artesunate, imatinib and infliximab – were

Latest news

  • Sanofi ships synthetic malaria jab Sanofi ships synthetic malaria jab

    Artesunate - the active ingredient produced from semisynthetic artemisinin - and semisynthetic artemisinin itself are identical to those derived from the natural world. ... The drugs were manufactured with semisynthetic artesunate in Morocco and are

  • S-A agrees malaria research project

    sub-Saharan Africa concerning the safety and efficacy of anti-malarial drug artesunate-amodaquine.

  • CSR in action

    It is the largest study ever conducted in sub-Saharan Africa into the safety and efficacy of our anti-malarial drug artesunate-amodaquine.

  • S-A wins award for malaria programme

    The Malaria Access to Medicines Programme has seen S-A and not-for-profit product developers, DNDi, develop and distribute anti-malarial treatment, Coarsucam, or ASAQ (artesunate amodiaquine winthrop) in the

  • R & D news in brief

    The study, published in the Lancet and funded by the Wellcome Trust, found that artesunate, a derivative of artemisinin, reduced mortality by 35 per cent in comparision with quinine. ... Study chief, Professor Nick White, said artesunate was easier to

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Interview: Charles Mgone, EDCTP Interview: Charles Mgone, EDCTP

    simplification of intravenous Artesunate treatment of severe childhood malaria; early studies on novel anti-TB vaccines and the establishment of networks for conducting clinical trials.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
IPG Health Medical Communications

We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity...

Latest intelligence

Biosimilars and beyond: innovating for improved patient outcomes
How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...

Quick links